Elsevier

Atherosclerosis

Volume 155, Issue 1, March 2001, Pages 19-28
Atherosclerosis

Characterization of peroxynitrite-oxidized low density lipoprotein binding to human CD36

https://doi.org/10.1016/S0021-9150(00)00524-4Get rights and content

Abstract

Peroxynitrite-mediated oxidation may be an important physiological mechanism for oxidation of low density lipoprotein (LDL), however, the molecular basis for the interaction of peroxynitrite oxidized LDL (OxLDL) with scavenger receptors such as CD36, has not been characterized. In this study, we compared the biochemical characteristics and receptor binding of LDL that was oxidized using: (1) Cu2+, a standard method of oxidizing LDL in vitro; and (2) 3-morpholinosydnonimine (SIN-1), a source of peroxynitrite. Both methods of oxidation caused an increase in electrophoretic migration of LDL, but greater mobility was observed with Cu2+-OxLDL. In addition, greater fragmentation of apolipoprotein B was observed following Cu2+ oxidation than after SIN-1 oxidation. The levels of lipid peroxides and thiobarbituric acid reactive substances were similar after 20 h of oxidation by both methods, although the time-course was distinct. Cu2+ and SIN-1-OxLDL bound specifically to the macrophage scavenger receptor CD36 with high affinity. Binding of the 20 h SIN-1 treated LDL to CD36 was comparable to a 4 h Cu2+ modified LDL. The binding of Cu2+ and SIN-1-OxLDL to CD36 was similar under different biochemical conditions and modifications of the receptor, suggesting that OxLDL particles, generated by either method, bind to the same domain of CD36. The results demonstrate that SIN-1 produced an oxidized LDL particle that binds specifically to CD36 and suggests that peroxynitrite OxLDL may represent a more physiologically relevant model than Cu2+-OxLDL for studying the interactions of OxLDL with cells and lipoprotein receptors in vitro.

Introduction

Several lines of evidence indicate a central role for oxidized low density lipoprotein (OxLDL) in the pathogenesis of atherosclerosis. Of particular relevance to atherogenesis has been the demonstration that OxLDL is recognized by scavenger receptors and contributes to the formation of foam cells (reviewed in [1], [2], [3], [4]). Based on in vitro studies, a variety of additional atherogenic properties have been attributed to OxLDL, including: the recruitment, retention, and proliferation of macrophages in the intima due to the release of chemotactic factors; enhanced expression of endothelial cell adhesion molecules; the induction of macrophage signaling pathways that include phosphatidylinositol 3-kinase [5], [6], [7], [8]; and cytotoxicity of endothelial cells and inhibition of NO-mediated vasodilation [9], [10], [11].

The exact mechanisms whereby LDL is oxidized in vivo are unknown. A variety of methods have been used to generate OxLDL in vitro, including endothelial or smooth muscle cell-mediated oxidation [12], [13], [14] and cell-free systems, in which oxidation is induced with: transition metals such as copper or iron [14], [15]; peroxynitrite [16], [17], [18]; myeloperoxidase [19], [20], [21]; or lipoxygenase [22], [23]. Because of its simplicity, generating maximally oxidized LDL by exposure to CuSO4 for 18–24 h, has become a standard method. However, Cu2+ oxidation does not correspond to a physiological event since free copper is not present in vivo. Furthermore, the ligand generated by maximally oxidizing LDL with CuSO4 may not be representative of OxLDL found in vivo, which is of particular importance for studies assessing the structure-function relationships of lipoprotein receptors with their ligands and the biologic effects of OxLDL [3].

A number of more physiologic mechanisms by which LDL may be oxidized in vivo have been identified. These include lipoxygenase enzymes, glycoxidation, peroxynitrite, and myeloperoxidase [16], [19], [20], [21], [22], [23]. Although the relative contribution of each of these to oxidative modification of LDL in vivo is unknown, recent evidence supports a role for peroxynitrite [24], [25]. Endothelial cells, monocytes, macrophages and neutrophils at the lesion site have the potential to produce both nitric oxide (NO) and superoxide (O2) [18], [25], [26], [27]. NO and O2 rapidly react to generate peroxynitrite (ONOO) which is a potent oxidizer of LDL in vitro [17], [28], [29]. In vitro, ONOO reacts with tyrosine to generate 3-nitrotyrosine, which has been shown to be a highly stable and specific marker for oxidative modification of LDL by peroxynitrite [24], [30]. Recent studies, indicating that LDL isolated from atherosclerotic lesions had 90-fold higher levels of 3-nitrotyrosine than plasma from healthy controls, provide strong evidence for the involvement of peroxynitrite oxidation of LDL in vivo [24], [25].

Several receptors have been implicated in the binding and uptake of OxLDL in vitro, including CD36, AcLDL-R, SR-BI, CD68/macrosialin and LOX-1 [31], [32], [33], [34], [35], [36]. The in vivo roles of these receptors in OxLDL uptake have yet to be elucidated, but recent studies support a role for CD36. CD36 is expressed on cells (monocytes/macrophages, endothelial cells and platelets) [37], and is known to participate in atherosclerosis. It has been shown to be a high affinity receptor for OxLDL and cells transfected with CD36 bind and internalize the particle [31], [34], [38]. It has recently been reported that CD36 also binds HDL, VLDL and LDL, but does not internalize these ligands [39], [40]. Evidence for an in vivo role for CD36 comes from studies by Nozaki et al. [41]. Macrophages from CD36-deficient individuals were shown to have a low capacity to bind, internalize and degrade OxLDL and they accumulated significantly less cholesterol ester than control macrophages. It has recently been shown that OxLDL up-regulates expression of CD36 via a PPARγ pathway [42], [43]. This could lead to enhanced uptake of OxLDL and foam cell formation via a positive feedback loop. NF-κB binding activity is enhanced following OxLDL binding to TNF-α activated cells expressing CD36, therefore, CD36 mediates signal transduction events in response to OxLDL [44].

Given the growing evidence supporting a role for both peroxynitrite-mediated oxidation of LDL and CD36 in atherogenesis, the objectives of this study were to compare and contrast Cu2+ and peroxynitrite oxidation of LDL, to characterize the biochemical changes in the particle and to examine the binding of LDL, oxidized by each method, to the scavenger receptor CD36. It was demonstrated that peroxynitrite-OxLDL is a suitable physiological model for studying lipoprotein-receptor and cellular interactions.

Section snippets

Isolation and oxidation of LDL

Human LDL was isolated from pooled serum by ultracentrifugation between densities 1.019 and 1.063g/ml at 45 000 rpm for 18 h at 10°C, using a model 50.3 Ti rotor in an L8-80 centrifuge (Beckman Instruments Inc. Fullerton, CA) [45]. Isolated LDL was dialyzed against 0.15 M NaCl, 0.24 mM Na2EDTA at pH 7.4 and diluted with 1 M glycine/NaOH buffer, pH 10.0, prior to iodination with Na125I (Amersham, IL) [46]. Unbound iodine was removed by chromatography on QAE-Sephadex A-25 (Pharmacia, Baie d'Urfe,

Kinetics of modification of LDL following Cu2+ and SIN-1 treatment

3-Morpholinosydnonomine hydrochloride (SIN-1) was selected as the source of peroxynitrite in these experiments since the reaction of SIN-1 with aqueous solutions immediately results in the simultaneous generation of equivalent amounts of NO and O2 that interact rapidly to form ONOO [18]. ONOO generated using SIN-1 oxidizes LDL [16], [53]. An analysis of the electrophoretic migration of LDL, on agarose gels, revealed an increase in the mobility of LDL following oxidative modification by

Discussion

A variety of techniques are used for oxidation of LDL in vitro and the LDL particles generated are complex and have not been fully characterized as to their chemical nature and extent of the damage to the LDL particle. Moreover, not all methods of oxidation are physiologically relevant. The aims of this study were 2-fold: (1) to determine whether a more physiological method of oxidation of LDL using SIN-1 to generate peroxynitrite, produces an oxidized particle with similar chemical and

Acknowledgements

This research was supported by the Medical Research Council of Canada (MT-13721) and the Heart and Stroke Foundation of Ontario (NA-3391). RG is supported by the Natural Sciences and Engineering Research Council of Canada. KCK was supported by a Career Award from the Ontario Ministry of Health.

References (71)

  • A. Graham et al.

    Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor

    FEBS Lett.

    (1993)
  • J.S. Beckman et al.

    Oxidative chemistry of peroxynitrite

    Methods Enzymol.

    (1994)
  • G. Endemann et al.

    CD36 is a receptor for oxidized low density lipoprotein

    J. Biol. Chem.

    (1993)
  • S.L. Acton et al.

    Expression cloning of SR-BI, a CD36-related class B scavenger receptor

    J. Biol. Chem.

    (1994)
  • N.N. Tandon et al.

    Isolation and characterization of platelet glycoprotein IV (CD36)

    J. Biol. Chem.

    (1989)
  • D. Calvo et al.

    Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL

    J. Lipid Res.

    (1998)
  • X. Gu et al.

    The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain

    J. Biol. Chem.

    (1998)
  • L. Nagy et al.

    Oxidized LDL regulates macrophage gene expression through ligand activation of PPARg

    Cell

    (1998)
  • P. Tontonoz et al.

    PPARg promotes monocyte/macrophage differentiation and uptake of oxidized LDL

    Cell

    (1998)
  • J.L. Goldstein et al.

    Receptor-mediated endocytosis of low-density lipoprotein in cultured cells

    Methods Enzymol.

    (1983)
  • R.P. Noble

    Electrophoretic separation of plasma lipoproteins in agarose gel

    J. Lipid Res.

    (1968)
  • G.F. Maguire et al.

    Sodium dodecyl sulfate-glycerol polyacrylamide slab gel electrophoresis for the resolution of apolipoproteins

    J. Lipid Res.

    (1989)
  • Z.Y. Jiang et al.

    Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein

    Anal. Biochem.

    (1992)
  • I. Crandall et al.

    Plasmodium falciparum: pfalhesin and CD36 form an adhesin/receptor pair that is responsible for the pH-dependent portion of cytoadherence/sequestration

    Exp. Parasitol.

    (1994)
  • S.F. Pearce et al.

    Recombinant glutathione S-transferase/CD36 fusion proteins define an oxidized low density lipoprotein-binding domain

    J. Biol. Chem.

    (1998)
  • K. Marsh et al.

    Plasmodium falciparum: the behavior of clinical isolates in an in vitro model of infected red blood cell sequestration

    Exp. Parasitol.

    (1988)
  • L. Serghides et al.

    The Plasmodium falciparum-CD36 interaction is modified by a single amino acid substitution in CD36

    Blood

    (1998)
  • M. Lougheed et al.

    Mechanism of uptake of copper-oxidized low density lipoprotein in macrophages is dependent on its extent of oxidation

    J. Biol. Chem.

    (1996)
  • R.P. Patel et al.

    Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, and copper

    J. Lipid Res.

    (1996)
  • L.G. Fong et al.

    Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100

    J. Lipid Res.

    (1987)
  • W. Jessup et al.

    The participation of nitric oxide in cell free- and its restriction of macrophage-mediated oxidation of low-density lipoprotein

    Biochim. Biophys. Acta

    (1992)
  • J.Z. Lucas et al.

    Plasmodium falciparum: thrombospondin mediates parasitized erythrocyte band 3-related adhesin binding

    Exp. Parasitol.

    (1998)
  • M. Van Heek et al.

    Cholesteryl hydroperoxyoctadecadienoate from oxidized low density lipoprotein inactivates platelet-derived growth factor

    J. Biol. Chem.

    (1998)
  • T. Biwa et al.

    Induction of murine macrophage growth by oxidized low density lipoprotein is mediated by granulocyte macrophage colony-stimulating factor

    J. Biol. Chem.

    (1998)
  • R. Ross

    Atherosclerosis — an inflammatory disease

    N. Engl. J. Med.

    (1999)
  • Cited by (0)

    View full text